Neuroscientist Rogier Min from the Amsterdam UMC has collaborated with Christiaan Levelt's lab from the Netherlands Institute ...

A study led by the University of Barcelona and the Spanish National Research Council's Institute for Advanced Chemistry of ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Phase 3 registrational trial for ersodetug in patients with tumor hyperinsulinism (HI) expected to commence in 2025; real-world patient benefit demonstrated in Expanded Access ProgramREDWOOD CITY, ...

The submission for treating paediatric plaque psoriasis is supported by outcomes from the Phase III PROTOSTAR study in ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

Netherlands: A recent study, published in Diabetes, Obesity and Metabolism has revealed that atrasentan, an endothelin ...

In the 1990s, overprescribing by doctors, along with aggressive and deceptive drug marketing by pharmaceutical companies, led ...

A new study found that Black women are more likely to die from breast cancer than white women, regardless of the tumor ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...